Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matija Snuderl

Showing results (201-210 of 270) with videos related to

Pageof 27
Sort By:
The American Journal of Surgical Pathology|October 19, 2020
YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood MeningiomasKathleen M Schieffer, Vibhuti Agarwal, Stephanie LaHaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survivalJonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Nature Biomedical Engineering|September 29, 2017
Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopyDaniel A Orringer, Balaji Pandian, Yashar S Niknafs, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Pageof 27

Showing results (201-210 of 270) with videos related to

Sort By:
Pageof 27
The American Journal of Surgical Pathology|October 19, 2020
YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood MeningiomasKathleen M Schieffer, Vibhuti Agarwal, Stephanie LaHaye, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 25, 2021
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibitionSarah Chiang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2016
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survivalJonas Kloepper, Lars Riedemann, Zohreh Amoozgar, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.
Nature Biomedical Engineering|September 29, 2017
Rapid intraoperative histology of unprocessed surgical specimens via fibre-laser-based stimulated Raman scattering microscopyDaniel A Orringer, Balaji Pandian, Yashar S Niknafs, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2013
Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiationTracy T Batchelor, Elizabeth R Gerstner, Kyrre E Emblem, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
Molecular Cancer Research : MCR|October 23, 2023
Impact of Rare and Multiple Concurrent Gene Fusions on Diagnostic DNA Methylation Classifier in Brain TumorsKristyn Galbraith, Jonathan Serrano, Guomiao Shen, et al.
Pageof 27